Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This extension study is designed to evaluate the long-term safety and tolerability of
colesevelam hydrochloride (WelChol®) in patients with type 2 diabetes.